A novel HER2-specific sensor based on DARPin_9–29 and albumin binding domain for real-time fluorescence-guided tumor detection in animal model of cancer
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von E I Shramova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Academy of Science, 16/10 Miklukho-Maklaya Street, Moscow, 117997, Russia. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
In animal models of cancer, targeted fluorescence bioimaging, performed non-invasively and in real time, is indispensable tool for assessing tumor location, spread of metastasis, and the therapeutic potential of anticancer drugs under development. To overcome the limitation of antibodies in bioimaging applications, small artificial scaffold proteins based on ankyrin repeats (DARPins, designed ankyrin repeat proteins) are used as tumor-associated antigen binders. In this study for the first time, we assessed the potential of DARPin_9-29, the human epidermal growth factor receptor 2 (HER2) subdomain I-specific protein, genetically fused with albumin binding domain (ABD) and conjugated with Cyanine5.5 as a NIR sensor for fluorescence bioimaging of HER2-positive cancer in animal model. In vivo biodistribution studies have revealed sufficient tumor-to-background ratios at 48 h (3.17 ± 0.55) and 72 h (3.49 ± 0.64) postinjection, providing excellent contrast between the primary tumor and tissue background and allowing clear breast tumor detection. Ex vivo biodistribution has shown that ABD module in DARP-ABD sensor prevents renal reabsorption and increases tumor accumulation in more than 10-folds compared to excreting organs. To verify if DARP-ABD-Cy5.5 can demarcate HER2-positive tumor in vivo, HER2-positive syngeneic breast cancer cell line with constitutive gene expression of luciferase eFFLuc, was created. The powerful combination of bioluminescence and fluorescence imaging let to track the fluorescent anti-HER2 DARP-ABD sensor in bioluminescent HER2-positive breast tumors. Our results validate DARP-ABD as a promising sensor for fluorescence-guided imaging of HER2-positive solid cancer, which can be used in the development of improved anticancer treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Academy of Science, 16/10 Miklukho-Maklaya Street, Moscow, 117997, Russia.
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Academy of Science, 16/10 Miklukho-Maklaya Street, Moscow, 117997, Russia; National Research Center "Kurchatov Institute", Moscow, 123182, Russia;…
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Academy of Science, 16/10 Miklukho-Maklaya Street, Moscow, 117997, Russia. Electronic address: gmb@ibch.ru.
Förderung
- Russian Science Foundation
Zitieren
APA
Shramova, E. I., Frolova, A. Y., Serova, E. V., Deyev, S. M., & Proshkina, G. M. (2024). A novel HER2-specific sensor based on DARPin_9–29 and albumin binding domain for real-time fluorescence-guided tumor detection in animal model of cancer. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150747
Vancouver
Shramova EI, Frolova AY, Serova EV, Deyev SM, Proshkina GM. A novel HER2-specific sensor based on DARPin_9–29 and albumin binding domain for real-time fluorescence-guided tumor detection in animal model of cancer. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150747
BibTeX
@article{Shramova2024,
author = {Shramova, E I and Frolova, A Yu and Serova, E V and Deyev, S M and Proshkina, G M},
title = {A novel HER2-specific sensor based on DARPin_9–29 and albumin binding domain for real-time fluorescence-guided tumor detection in animal model of cancer},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150747}
}
EUVIMED